What is the appropriate treatment for a 5 mm right‑sided renal stone in a woman who now has back pain and lower abdominal discomfort?

Treatment for 5 mm Right-Sided Kidney Stone with Pain

For a 5 mm right-sided renal stone causing back and lower abdominal pain, immediate pain control with NSAIDs (diclofenac, ibuprofen, or metamizole) is first-line treatment, followed by medical expulsive therapy with an alpha-blocker if the stone has moved into the ureter, or active surveillance with serial imaging if it remains in the kidney 1.

Immediate Pain Management

The priority is controlling her renal colic symptoms:

• NSAIDs are first-line: Give diclofenac 50-100 mg rectally or 75 mg IM, ibuprofen, or metamizole 1
• NSAIDs are superior to opioids for reducing additional analgesia needs 1
• Use opioids only as second-line if NSAIDs are contraindicated (avoid pethidine; prefer hydromorphine, pentazocine, or tramadol) 1
• Use the lowest effective NSAID dose due to cardiovascular, gastrointestinal, and renal function risks 1

Critical Red Flags to Rule Out Immediately

Before proceeding with conservative management, urgently assess for:

• Fever or signs of sepsis: Requires immediate urinary decompression via nephrostomy or ureteral stent 1
• Anuria: Also requires urgent decompression 1
• Obtain urine culture before any intervention if infection suspected 1

Determining Stone Location (Critical for Treatment Decision)

Obtain imaging to determine if the stone is still in the kidney or has moved to the ureter 2:

• If the stone has descended into the distal ureter (most likely given her lower abdominal pain), this changes management significantly
• CT is most reliable for determining exact location, size, and density 2
• Ultrasound is acceptable as first-line but may miss ureteral stones 1

Treatment Algorithm Based on Stone Location

If Stone is in the Distal Ureter (≤10 mm):

Offer medical expulsive therapy (MET) with any alpha-blocker for approximately 30 days 2:

• Options include tamsulosin, alfuzosin, doxazosin, terazosin, or silodosin
• This is a strong recommendation based on evidence from >8000 patients showing increased stone passage rates, reduced pain episodes, fewer emergency visits, and less need for surgery 2
• The greatest benefit is for stones >5 mm in the distal ureter 1

If Stone Remains in the Kidney:

Active surveillance is appropriate for a 5 mm asymptomatic renal stone, but given her symptoms:

• About 20% of stones ≤5 mm require surgical intervention within 5 years 3
• Stone size >4 mm is a predictor of future intervention need 4
• Follow-up imaging every 6 months to monitor for growth, migration, or complications 3
• Consider surgical intervention if: stone grows, symptoms persist, urinary obstruction develops, or recurrent infections occur 5

If Stone is in Proximal/Middle Ureter:

May offer MET with alpha-blockers, though evidence is weaker than for distal stones 2

• Consider ureteroscopy if MET fails or patient prefers definitive treatment

Follow-Up Imaging Timeline

• Obtain follow-up imaging within 14 days to monitor stone position and assess for hydronephrosis 5
• Earlier imaging if symptoms worsen or red flags develop

Common Pitfalls to Avoid

1. Don't assume all flank pain is simple colic: Always rule out infection/sepsis before conservative management
2. Don't use pethidine if opioids are needed—it causes more vomiting and requires more rescue analgesia 1
3. Don't proceed with definitive surgery if bacteriuria/funguria present—treat infection first with culture-specific antibiotics 2
4. Don't rely on ultrasound alone for ureteral stones—it has poor sensitivity for stones that have migrated 6, 7

When to Refer for Surgical Intervention

Consider ureteroscopy or other intervention if:

• Stone >10 mm (unlikely to pass spontaneously) 7
• MET fails after 30 days
• Persistent obstruction after initial treatment
• Patient develops infection, anuria, or intractable pain
• Patient preference for definitive treatment

The key decision point is determining whether this 5 mm stone is still in the kidney or has migrated to the ureter—this fundamentally changes whether MET is strongly indicated versus surveillance being more appropriate 1, 2.